{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:06Z","timestamp":1790704326697,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/inf.0000000000000712","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T04:15:52Z","timestamp":1428466552000},"page":"e169-e175","source":"Crossref","is-referenced-by-count":15,"title":["Antiretroviral Therapy Use During Pregnancy and the Risk of Small for Gestational Age Birth in a Medicaid Population"],"prefix":"10.1097","volume":"34","author":[{"given":"Kelesitse","family":"Phiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate B.","family":"Dugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William O.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Seage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hernandez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-16-20210202","doi-asserted-by":"crossref","first-page":"F241","DOI":"10.1097\/00002030-199818000-00002","article-title":"Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.","volume":"12","author":"Lorenzi","year":"1998","journal-title":"AIDS"},{"key":"R7-16-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e328133884b","article-title":"Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.","volume":"21","author":"Townsend","year":"2007","journal-title":"AIDS"},{"key":"R8-16-20210202","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/sti.2008.032300","article-title":"Pregnancy outcome in women infected with HIV-1 receiving combination antiretroviral therapy before versus after conception.","volume":"85","author":"Machado","year":"2009","journal-title":"Sex Transm Infect"},{"key":"R9-16-20210202","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/infdis\/jir307","article-title":"Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy.","volume":"204","author":"Powis","year":"2011","journal-title":"J Infect Dis"},{"key":"R10-16-20210202","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/infdis\/jis553","article-title":"Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana.","volume":"206","author":"Chen","year":"2012","journal-title":"J Infect Dis"},{"key":"R11-16-20210202","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa991159","article-title":"Antiretroviral therapy during pregnancy and the risk of an adverse outcome.","volume":"346","author":"Tuomala","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-16-20210202","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.qai.0000139398.38236.4d","article-title":"Women and Infants Transmission Study. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.","volume":"38","author":"Tuomala","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.qai.0000174651.40782.95","article-title":"Protease inhibitor use in 233 pregnancies.","volume":"40","author":"Morris","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R15-16-20210202","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/651232","article-title":"P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.","volume":"201","author":"Patel","year":"2010","journal-title":"J Infect Dis"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/INF.0000000000000251","article-title":"First trimester exposure to antiretroviral therapy and risk of birth defects.","volume":"33","author":"Phiri","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R17-16-20210202","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/oxfordjournals.aje.a115692","article-title":"Methodological issues in evaluating expanded Medicaid coverage for pregnant women.","volume":"132","author":"Piper","year":"1990","journal-title":"Am J Epidemiol"},{"key":"R18-16-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/pds.1534","article-title":"Positive predictive value of computerized records for major congenital malformations.","volume":"17","author":"Cooper","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R20-16-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/apc.2013.0165","article-title":"Trends in antiretroviral drug use during pregnancy among HIV-infected women on Medicaid: 2000-2007.","volume":"28","author":"Phiri","year":"2014","journal-title":"AIDS Patient Care STDS"},{"key":"R22-16-20210202","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1097\/QAD.0b013e32832be0df","article-title":"ANRS French Perinatal Cohort. No relation between in-utero exposure to HAART and intrauterine growth retardation.","volume":"23","author":"Briand","year":"2009","journal-title":"AIDS"},{"key":"R23-16-20210202","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1093\/infdis\/jis728","article-title":"Pediatric HIVAIDS Cohort Study. Combination antiretroviral use and preterm birth.","volume":"207","author":"Watts","year":"2013","journal-title":"J Infect Dis"},{"key":"R24-16-20210202","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/QAI.0b013e31817bbe80","article-title":"PACTG 1025 Protocol Team. Adherence to antiretrovirals among US women during and after pregnancy.","volume":"48","author":"Bardeguez","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-16-20210202","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/apc.2008.0125","article-title":"Correlates of perinatal depression in HIV-infected women.","volume":"23","author":"Kapetanovic","year":"2009","journal-title":"AIDS Patient Care STDS"},{"key":"R26-16-20210202","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1089\/apc.2012.0013","article-title":"NISDI LILAC Study Team. Antiretroviral adherence during pregnancy and postpartum in Latin America.","volume":"26","author":"Kreitchmann","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"R27-16-20210202","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/QAD.0b013e328359590f","article-title":"Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis.","volume":"26","author":"Nachega","year":"2012","journal-title":"AIDS"},{"key":"R28-16-20210202","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1093\/ajcn\/74.6.814","article-title":"Determinants of low birth weight among HIV-infected pregnant women in Tanzania.","volume":"74","author":"Dreyfuss","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3945\/jn.113.178616","article-title":"HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants.","volume":"144","author":"Ramokolo","year":"2014","journal-title":"J Nutr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000712","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:00Z","timestamp":1620954420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201507000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000712","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}